SIMCOR® (niacin extended-release/simvastatin tablets)

Helpful Resources

Framingham Risk Calculator

The interactive Framingham Risk Calculator:

Helps you evaluate your patient’s estimated risk of CHD over the next 10 years, based on the Framingham Study1
When you input your patient’s history and lab values, this useful interactive tool
  • Estimates CHD risk
  • Displays target levels for LDL-C, HDL-C, TG, and non–HDL-C based on risk factors

Download the Framingham Risk Calculator

The Framingham Risk Calculator is available as a downloadable file for your PC or Mac. Or, if you prefer, access the Risk Assessment Tool online right here.

Launch the Framingham Risk Calculator Download the Framingham Risk Calculator Download the Framingham Risk Calculator

How to Use the Framingham Risk Calculator

Complete all information in sections marked with an asterisk (*). The other values are not necessary to calculate Framingham 10-year risk, but are used to evaluate treatment targets.

How to Use the Framingham Risk Calculator

This portion of the calculator asks questions related to your patient's physical attributes and behaviors, and current or past medical history.

Panel 3 covers lipid profile. You can input your patient’s information by using numerical values in the window at the right of the section, or by dragging the sliders with your mouse until the correct value for each blood lipid value appears in the window at the right.

When you have finished entering information, click the Calculate button at the lower right of the Risk Assessment Tool.

The Framingham 10-year risk estimate (%) will appear in the calculations box.

Target lipid values will appear in the Targets box.

To enter a new patient, simply change all the values and review the results live, or choose "Clear Values" and start over.

Reference

  1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106:3143-3421